Solid Tumor With Intermediate or High HER2 Expression
1 clinical trials · Condition
◉ Watch Solid Tumor With Intermediate or High HER2 Expression
| Record | Firm | Date |
|---|---|---|
| Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients (NCT03924466) | Universitair Ziekenhuis Brussel | 2019-04-01 |
Track Solid Tumor With Intermediate or High HER2 Expression automatically
Every clearance here is in the API, with alerts when new ones post.